Vertex, Inc.VERXEarnings & Financial Report
Nasdaq · Information Technology · Services-Prepackaged Software
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Amanda Radcliffe | 21.30% | 33.3M | flat | 2024-11-13 |
| The Vanguard Group | 10.28% | 6.7M | ▲ +1.16pp | 2024-10-02 |
| BlackRock, Inc. | 7.70% | 5.0M | flat | 2024-11-12 |
| Arthur C. Young | 6.14% | 4.1M | ▼ -2.34pp | 2024-11-14 |
| s/ | 6.02% | 3.7M | — | 2024-02-12 |
| Conestoga Capital Advisors, LLC | 5.01% | 3.0M | — | 2024-01-05 |
| Alger Associates, Inc. | 3.90% | 2.5M | ▼ -3.40pp | 2024-11-14 |
| NOS. OF ABOVE PERSONS | 3.50% | 2.1M | — | 2023-12-07 |
Insider Transactions
Net 90d: +$3.28M · buys $3.28M / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-09 | 2001 ITEM SECOND IRR. TRUST FBO KYLE R. WESTPHAL u/a of JEFFREY R. WESTPHAL dated October 5 | 10% Owner | Buy (open market) | 10.0K | $15.05 | $150.5K |
| 2026-02-24 | DeStefano David | Director | Option exercise | 109.2K | $0.00 | $0 |
| 2026-02-23 | SCHWAB JOHN R | CHIEF FINANCIAL OFFICER | Option exercise | 30.3K | $0.00 | $0 |
| 2026-02-23 | Young Christopher David | President and CEO | Buy (open market) | 60.0K | $12.18 | $730.8K |
| 2026-02-23 | Rowland Bryan T.R. | GENERAL COUNSEL | Option exercise | 6.4K | $0.00 | $0 |
| 2026-02-23 | DeStefano David | Director | Option exercise | 101.4K | $0.00 | $0 |
| 2026-02-20 | DeStefano David | Director | Option exercise | 69.5K | $0.00 | $0 |
| 2026-02-20 | DeStefano David | Director | Option exercise | 44.0K | $0.00 | $0 |
| 2026-02-20 | SCHWAB JOHN R | CHIEF FINANCIAL OFFICER | Option exercise | 23.9K | $0.00 | $0 |
| 2026-02-20 | SCHWAB JOHN R | CHIEF FINANCIAL OFFICER | Option exercise | 15.9K | $0.00 | $0 |
1–10 of 16
Page 1 / 2